Wisconsin physicians' knowledge and attitudes about opioid analgesic regulations.

This pilot study was designed to evaluate physician knowledge of the controlled substance regulations that govern the prescribing of opioids and whether concerns about regulatory scrutiny affect reported prescribing practices. Two hundred Wisconsin physicians were surveyed, and 90 (45%) of the questionnaires were evaluable. Approximately 50% of the responses to questions about controlled substance regulations were incorrect. Concern about regulatory scrutiny ranked low compared to concerns about addiction and other opioid side effects. However, 54% of the respondents indicated that, due to concern of regulatory scrutiny, they will do one of the following: reduce drug dose or quantity, reduce the number of refills, or choose a drug in a lower schedule. These results indicate that many physicians have poor knowledge of controlled substances regulations and that the perceived risk of regulatory scrutiny can alter physician prescribing practice. Implications for patient care, policy and further research are discussed.